Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial
Sam Amin, Andrew A. Mallick, Hannah B Edwards, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100715-100715
Open Access | Times Cited: 23

Showing 23 citing articles:

Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Eleonora Aronica, Nicola Specchio, Mark J. Luinenburg, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2694-2710
Open Access | Times Cited: 38
Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 31
Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy
Nicola Specchio, Rima Nabbout, Eleonora Aronica, et al.
European Journal of Paediatric Neurology (2023) Vol. 47, pp. 25-34
Open Access | Times Cited: 28
New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 3953-3965
Open Access | Times Cited: 24
Two distinct phenotypes in Snijders Blok-Campeau syndrome and characterization of the behavioral phenotype in a zebrafish model
Yumi Enomoto, Takashi Shiromizu, Sakyo Yasojima, et al.
European Journal of Human Genetics (2025)
Closed Access | Times Cited: 1
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial
Martin Voß, Katharina J. Wenger, Nina von Mettenheim, et al.
European Journal of Nutrition (2021) Vol. 61, Iss. 1, pp. 477-487
Open Access | Times Cited: 39
Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review
Claudia Maria Jurca, Kinga Kozma, Codruţa Diana Petcheşi, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 433-433
Open Access | Times Cited: 14
Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm
Debopam Samanta
Epilepsy & Behavior (2024) Vol. 161, pp. 110123-110123
Closed Access | Times Cited: 5
The development and benefits of metformin in various diseases
Ying Dong, Yingbei Qi, Haowen Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 388-431
Closed Access | Times Cited: 12
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets
Elena Conte, Brigida Boccanegra, Giorgia Dinoi, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1190-1190
Open Access | Times Cited: 4
A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis
Ratnav Singh, Sudhir Chandra Sarangi, Surender Singh, et al.
Seizure (2022) Vol. 101, pp. 253-261
Open Access | Times Cited: 19
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
Laura Mihaela Isop, Andrea Elena Neculau, Radu Necula, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 10
Metformin: Beyond Diabetes Management to Neuroprotection and Cognitive Enhancement
Priyanka Gupta, Sirshak Dutta, Rajiv Jash, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Tuberous Sclerosis Complex: New Insights into Pathogenesis and Therapeutic Breakthroughs
Aurora Jurca, Alexandru Daniel Jurcă, Codruţa Diana Petcheşi, et al.
Life (2025) Vol. 15, Iss. 3, pp. 368-368
Open Access
Epilepsy and autophagy modulators: a therapeutic split
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Autophagy (2025)
Open Access
AMPK role in epilepsy: a promising therapeutic target?
Yingbei Qi, Yong-Mei Zhang, Ya-nan Gao, et al.
Journal of Neurology (2023) Vol. 271, Iss. 2, pp. 748-771
Closed Access | Times Cited: 8
Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study
Kaiping Zhou, Huan Yang, Zhihao Xie, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Subependymal Giant Cell Astrocytoma: The Molecular Landscape and Treatment Advances
Emanuela Pucko, Dorota Sulejczak, Robert P. Ostrowski
Cancers (2024) Vol. 16, Iss. 19, pp. 3406-3406
Open Access | Times Cited: 2
Tuberous Sclerosis Complex and the kidneys: what nephrologists need to know
Aline Grosskopf Monich, John J. Bissler, Fellype Carvalho Barreto
Brazilian Journal of Nephrology (2024) Vol. 46, Iss. 3
Open Access | Times Cited: 1
The Spectrum of "TFEopathies" - Flipping the mTOR Switch in Renal Tumorigenesis
Nicola Alesi, Kaushal Asrani, Tamara L. Lotan, et al.
Physiology (2024) Vol. 39, Iss. 6, pp. 347-359
Closed Access | Times Cited: 1
Drug arrows in the quiver-antiseizure, antiepileptic and neuroprotective medication: treatment and future aspects. A Focused Review
Elinor Ben‐Menachem
Seizure (2024)
Closed Access | Times Cited: 1
Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment
Mateusz Pieróg, Katarzyna Socała, Dorota Nieoczym, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3810-3810
Open Access | Times Cited: 2
Complexo da Esclerose Tuberosa e rins: o que os nefrologistas devem saber
Aline Grosskopf Monich, John J. Bissler, Fellype Carvalho Barreto
Brazilian Journal of Nephrology (2024) Vol. 46, Iss. 3
Open Access
Metformin for the management of tuberous sclerosis: What does the evidence tell us?
Anirudh Srinivasan, Beti Naga Shashi Kiran, Abdulla Koduvath, et al.
PubMed (2021)
Closed Access | Times Cited: 2
Page 1

Scroll to top